Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
GRI Bio Inc a biotechnology company advancing an innovative pipeline of Natural Killer T cell modulators for the treatment of inflammatory fibrotic and autoimmune diseases today announced that the Korean
For pharma and biopharma companies building quality into your products from an early stage is a key factor in regulatory approval and market successThus the FDA mentions Design of Experiments DoEas an essential tool for achieving both regulatory comp...
Merck a leading science and technology company has launched the first allinone validated genetic stability assay of its kind The Aptegra CHO genetic stability assay leverages whole genome
When developing new drugs nutritional products or pesticides its critical that unknown molecules are identified correctly But accurate identification is a lengthy process and all too often unsuccessful
CorMedix Inc a biopharmaceutical company focused on developing and commercializing therapeutic products for lifethreatening diseases and conditions today announced DefenCath
Dot Compliance a provider of AIenabled Quality Management System solutions today announced it has raised million in Series B extension funding marking a significant upround
Neumora Therapeutics Inc a clinicalstage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and preclinical brain disease programs today announced that the Phase trial of NMRA has been placed on clinical hold by the...
Nxera Pharma Co Ltd formerly known as Sosei Group or Sosei Heptares today announces that its operating business Nxera Pharma Korea has entered into an exclusive supply
Nanoform Finland Plc today announced a strategic partnership whereby CBC Co Ltd will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoforms
Boundless Bio a clinicalstage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogeneamplified cancers
